Placebo
SB-110-007
Phase 3 small_molecule active
Quick answer
Placebo for Leber congenital amaurosis (LCA) is a Phase 3 program (small_molecule) at Laboratoire HRA Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratoire HRA Pharma
- Indication
- Leber congenital amaurosis (LCA)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active